RT Journal Article
SR Electronic
T1 ERK5 Is a Potential Therapeutic Target in ALK-Positive Neuroblastoma
JF Cancer Discovery
JO CANCER DISCOVERY
FD American Association for Cancer Research
SP 1363
OP 1363
DO 10.1158/2159-8290.CD-RW2014-229
VO 4
IS 12
YR 2014
UL http://cancerdiscovery.aacrjournals.org/content/4/12/1363.2.abstract
AB ERK5 promotes ALK-induced transcription of MYCN and enhances neuroblastoma cell proliferation.